108 related articles for article (PubMed ID: 11955274)
1. Redirecting cytotoxic T lymphocyte responses with T-cell receptor transgenes.
Clay TM; Morse M; Lyerly HK
Expert Opin Biol Ther; 2002 Apr; 2(4):353-60. PubMed ID: 11955274
[TBL] [Abstract][Full Text] [Related]
2. Genetic engineering of T cell specificity for immunotherapy of cancer.
Willemsen RA; Debets R; Chames P; Bolhuis RL
Hum Immunol; 2003 Jan; 64(1):56-68. PubMed ID: 12507815
[TBL] [Abstract][Full Text] [Related]
3. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
[TBL] [Abstract][Full Text] [Related]
4. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
5. Generation of chimeric T-cell receptor transgenes and their efficient transfer in primary mouse T lymphocytes.
Howland LJ; Haynes NM; Darcy PK
Methods Mol Biol; 2010; 651():291-306. PubMed ID: 20686973
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.
Coccoris M; Straetemans T; Govers C; Lamers C; Sleijfer S; Debets R
Expert Opin Biol Ther; 2010 Apr; 10(4):547-62. PubMed ID: 20146634
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.
Joseph A; Zheng JH; Follenzi A; Dilorenzo T; Sango K; Hyman J; Chen K; Piechocka-Trocha A; Brander C; Hooijberg E; Vignali DA; Walker BD; Goldstein H
J Virol; 2008 Mar; 82(6):3078-89. PubMed ID: 18184707
[TBL] [Abstract][Full Text] [Related]
8. Exploiting T cell receptor genes for cancer immunotherapy.
Xue S; Gillmore R; Downs A; Tsallios A; Holler A; Gao L; Wong V; Morris E; Stauss HJ
Clin Exp Immunol; 2005 Feb; 139(2):167-72. PubMed ID: 15654813
[TBL] [Abstract][Full Text] [Related]
9. T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens.
Ivanov R; Hol S; Aarts TI; Hagenbeek A; Ebeling SB
Clin Exp Immunol; 2006 Jan; 143(1):78-84. PubMed ID: 16367937
[TBL] [Abstract][Full Text] [Related]
10. Prospects and limitations of T cell receptor gene therapy.
Jorritsma A; Schotte R; Coccoris M; de Witte MA; Schumacher TN
Curr Gene Ther; 2011 Aug; 11(4):276-87. PubMed ID: 21453279
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.
Kalams SA; Johnson RP; Trocha AK; Dynan MJ; Ngo HS; D'Aquila RT; Kurnick JT; Walker BD
J Exp Med; 1994 Apr; 179(4):1261-71. PubMed ID: 8145043
[TBL] [Abstract][Full Text] [Related]
12. T-cell receptor gene therapy in human melanoma-bearing immune-deficient mice: human but not mouse T cells recapitulate outcome of clinical studies.
Straetemans T; Coccoris M; Berrevoets C; Treffers-Westerlaken E; Scholten CE; Schipper D; Ten Hagen TL; Debets R
Hum Gene Ther; 2012 Feb; 23(2):187-201. PubMed ID: 21958294
[TBL] [Abstract][Full Text] [Related]
13. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
14. Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer.
Scholten KB; Schreurs MW; Ruizendaal JJ; Kueter EW; Kramer D; Veenbergen S; Meijer CJ; Hooijberg E
Clin Immunol; 2005 Feb; 114(2):119-29. PubMed ID: 15639645
[TBL] [Abstract][Full Text] [Related]
15. Generation of human islet-specific regulatory T cells by TCR gene transfer.
Hull CM; Nickolay LE; Estorninho M; Richardson MW; Riley JL; Peakman M; Maher J; Tree TI
J Autoimmun; 2017 May; 79():63-73. PubMed ID: 28117148
[TBL] [Abstract][Full Text] [Related]
16. T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.
Flerin NC; Chen H; Glover TD; Lamothe PA; Zheng JH; Fang JW; Ndhlovu ZM; Newell EW; Davis MM; Walker BD; Goldstein H
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077649
[TBL] [Abstract][Full Text] [Related]
17. Two ultraviolet tumor-specific suppressor cell clones. One expresses Ig RNA and the other expresses T cell receptor-alpha and -beta RNA.
Kraig E; Kannapell CC; Fischbach K; Zellmer V; Trial J
J Immunol; 1990 Oct; 145(7):2050-6. PubMed ID: 2168916
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of TCR expression vectors for the construction of mouse-human chimeric MBP-specific TCR transgenes.
Baker AM; Wang Y; Richert JR
J Neurosci Res; 1996 Aug; 45(4):487-91. PubMed ID: 8872910
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with TCR-redirected T cells: comparison of TCR-transduced and TCR-engineered hematopoietic stem cell-derived T cells.
Stärck L; Popp K; Pircher H; Uckert W
J Immunol; 2014 Jan; 192(1):206-13. PubMed ID: 24293634
[TBL] [Abstract][Full Text] [Related]
20. Redirecting T lymphocyte specificity by T cell receptor gene transfer--a new era for immunotherapy.
Engels B; Uckert W
Mol Aspects Med; 2007 Feb; 28(1):115-42. PubMed ID: 17307249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]